Fig. 4From: Randomized placebo-controlled clinical trial investigating the effect of antioxidants and a vasodilator on overall safety and residual hearing preservation in cochlear implant patientsIndividual hearing loss 3 months after the first fitting in ACEMg- or placebo-treated patients of the ITT and PP populationBack to article page